Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma
- PMID: 17557961
- PMCID: PMC4036441
- DOI: 10.1200/JCO.2007.11.1419
Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma
Conflict of interest statement
The author(s) indicated no potential conflicts of interest.
Similar articles
-
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.Jpn J Clin Oncol. 2009 Jul;39(7):456-9. doi: 10.1093/jjco/hyp034. Epub 2009 Apr 24. Jpn J Clin Oncol. 2009. PMID: 19395465
-
Successful resection of mediastinal seminoma evaluated the response to induction chemotherapy with fluorodeoxyglucose-positron emission tomography.Ann Thorac Cardiovasc Surg. 2012;18(1):45-7. doi: 10.5761/atcs.cr.11.01667. Epub 2011 Aug 26. Ann Thorac Cardiovasc Surg. 2012. PMID: 21881343
-
Pathological complete response with cocktail chemotherapy in mediastinal seminoma.BMJ Case Rep. 2025 Mar 19;18(3):e261999. doi: 10.1136/bcr-2024-261999. BMJ Case Rep. 2025. PMID: 40107737
-
[Intra-arterial infusion chemotherapy for liver metastases of testicular tumors: report of two cases].Hinyokika Kiyo. 2000 Nov;46(11):823-7. Hinyokika Kiyo. 2000. PMID: 11193306 Review. Japanese.
-
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.Arch Ital Urol Androl. 2002 Jun;74(2):81-5. Arch Ital Urol Androl. 2002. PMID: 12161942 Review.
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
-
- Collins DH, Pugh RCB. Classification and frequency of testicular cancer. Br J Urol. 1964;36(suppl 1):1–11. - PubMed
-
- Bokemeyer C, Nichols CR, Draz JP, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis. J Clin Oncol. 2002;20:1864–1873. - PubMed
-
- De Santis M, Becherer A, Bokemeyer C, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol. 2004;22:1034–1039. - PubMed
-
- Puc HS, Heelan R, Mazumdar M, et al. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol. 1996;14:454–460. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical